Athira Inks $4M FCA Deal Over Ex-CEO's Research Fraud
By Rae Ann Varona · January 6, 2025, 11:05 PM EST
Athira Pharma Inc. has agreed to pay $4 million to resolve allegations it used falsified academic research papers on neurological disorders like Alzheimer's to secure federal grants from the National Institute...
To view the full article, register now.